The real costs of emesis—An economic analysis of ondansetron vs. Metoclopramide in controlling emesis in patients receiving chemotherapy for cancer
- 31 December 1993
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (3) , 303-306
- https://doi.org/10.1016/0959-8049(93)90372-m
Abstract
No abstract availableKeywords
This publication has 1 reference indexed in Scilit:
- On the receiving end—patient perception of the side-effects of cancer chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1983